Research Driven Drug Discovery
Discovery is an independent, research driven drug discovery company dedicated to the development of novel and innovative therapeutics.
Ubiquitin Specific Proteases
Deubiquitinating enzymes (DUBs) and their subset ubiquitin specific proteases (USP’s) hold the promise of producing many new drugs across a wide range of indications.
Protein Drug Conjugates
Antibodies and proteins are a key element of a clinican’s arsenal of therapeutics but they are not perfect. The improvements needed will require notable new technologies. Almac Discovery is exploring drug conjugates as the way forward.
Latest from Almac Discovery
Almac Discovery to Present Updates on Key Oncology Programmes at the 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II
Almac Discovery Enters Into Licensing Agreement for the Development & Commercialisation of ALM301
Almac Discovery to Collaborate with MSD on selected DUB therapeutic targets
Debiopharm Advances its Potent Wee1 Inhibitor into Clinical Phase
Key Research Areas
Almac Discovery specialise in Ubiquitin Specific Proteases (USPs)Read more
Discovery News & Events
Stay up to date with all the latest news and events at Almac Discovery.Read more